627 related articles for article (PubMed ID: 25534509)
1. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
Bassuk SS; Manson JE
Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
3. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
4. Current recommendations: what is the clinician to do?
Manson JE
Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy.
Bhavnani BR; Strickler RC
J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
[TBL] [Abstract][Full Text] [Related]
6. What the Women's Health Initiative has taught us about menopausal hormone therapy.
Chester RC; Kling JM; Manson JE
Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
[TBL] [Abstract][Full Text] [Related]
7. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
8. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
[TBL] [Abstract][Full Text] [Related]
9. Sex hormones and cardiovascular risk.
La Vecchia C
Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
[TBL] [Abstract][Full Text] [Related]
10. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
11. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
12. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraception and risk of cardiovascular disease. An international perspective.
Farley TM; Collins J; Schlesselman JJ
Contraception; 1998 Mar; 57(3):211-30. PubMed ID: 9617537
[TBL] [Abstract][Full Text] [Related]
15. The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Bassuk SS; Manson JE
Metabolism; 2016 May; 65(5):794-803. PubMed ID: 27085786
[TBL] [Abstract][Full Text] [Related]
16. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.
Grodstein F; Manson JE; Stampfer MJ; Rexrode K
Arch Intern Med; 2008 Apr; 168(8):861-6. PubMed ID: 18443262
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
19. The hormone continuum: accrual of women's health benefits.
Linn ES; Kaunitz AM; Schnare S; Taylor M
Int J Fertil Womens Med; 2001; 46(2):60-72. PubMed ID: 11374657
[TBL] [Abstract][Full Text] [Related]
20. Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study.
Bhupathiraju SN; Grodstein F; Stampfer MJ; Willett WC; Hu FB; Manson JE
Am J Public Health; 2016 Sep; 106(9):1631-7. PubMed ID: 27459451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
